In this episode, Sam sits down with Max Bronstein, a leader in biopharmaceutical innovation and health policy, to discuss the future of healthcare. From expanding access to genomic technologies to rethinking drug development models, Max shares insights from his work at the White House Office of Science and Technology Policy and beyond. They explore the challenges of scaling solutions for unmet medical needs, the promise of public-private collaborations, and preparing for the next wave of transformative healthcare innovations.

Ver todos los episodios